- Report
- December 2022
Czech Republic
From €2281EUR$2,500USD£1,949GBP
- Report
- December 2022
Cyprus
From €2281EUR$2,500USD£1,949GBP
- Report
- December 2022
Croatia
From €2281EUR$2,500USD£1,949GBP
- Report
- December 2022
Sweden
From €2281EUR$2,500USD£1,949GBP
- Report
- December 2022
Slovenia
From €2281EUR$2,500USD£1,949GBP
- Report
- December 2022
Slovakia
From €2281EUR$2,500USD£1,949GBP
- Report
- December 2022
Serbia
From €2281EUR$2,500USD£1,949GBP
- Report
- December 2022
Norway
From €2281EUR$2,500USD£1,949GBP
- Report
- December 2022
Netherlands
From €2281EUR$2,500USD£1,949GBP
- Report
- December 2022
Moldova
From €2281EUR$2,500USD£1,949GBP
- Report
- December 2022
Malta
From €2281EUR$2,500USD£1,949GBP
- Report
- December 2022
Ireland
From €2281EUR$2,500USD£1,949GBP
- Report
- December 2022
Iceland
From €2281EUR$2,500USD£1,949GBP
- Report
- December 2022
Hungary
From €2281EUR$2,500USD£1,949GBP
- Report
- December 2022
Portugal
From €2281EUR$2,500USD£1,949GBP
- Report
- December 2022
Poland
From €2281EUR$2,500USD£1,949GBP
- Report
- December 2022
Albania
From €2281EUR$2,500USD£1,949GBP
- Report
- December 2022
Bulgaria
From €2281EUR$2,500USD£1,949GBP
- Report
- December 2022
Russia
From €2281EUR$2,500USD£1,949GBP
- Report
- December 2022
Romania
From €2281EUR$2,500USD£1,949GBP

Pneumonia is an infectious disease caused by bacteria, viruses, or fungi that affects the lungs. It is one of the most common infectious diseases and is a leading cause of death worldwide. Infectious disease testing is used to diagnose and monitor the progression of pneumonia. Tests used to diagnose pneumonia include chest X-rays, sputum cultures, and blood tests. Treatment for pneumonia typically involves antibiotics, antivirals, and other medications.
The pneumonia market within the context of infectious disease testing is a rapidly growing market. It is driven by the increasing prevalence of pneumonia, the development of new diagnostic technologies, and the increasing demand for rapid and accurate diagnosis. The market is expected to grow due to the increasing prevalence of pneumonia, the development of new diagnostic technologies, and the increasing demand for rapid and accurate diagnosis.
Some companies in the pneumonia market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more